Published in J Alzheimers Dis on January 01, 2010
Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease. PLoS One (2011) 1.32
Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients. Transl Psychiatry (2012) 1.31
Genome-wide pathway analysis of memory impairment in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort implicates gene candidates, canonical pathways, and networks. Brain Imaging Behav (2012) 1.00
Polysialylated NCAM and ephrinA/EphA regulate synaptic development of GABAergic interneurons in prefrontal cortex. Cereb Cortex (2012) 0.86
Global analysis of S-nitrosylation sites in the wild type (APP) transgenic mouse brain-clues for synaptic pathology. Mol Cell Proteomics (2014) 0.83
Brain structure, cognition and negative symptoms in schizophrenia are associated with serum levels of polysialic acid-modified NCAM. Transl Psychiatry (2015) 0.78
Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability. Alzheimers Dement (2016) 0.78
Synaptic Cell Adhesion Molecules in Alzheimer's Disease. Neural Plast (2016) 0.76
Serum Markers of Neurodegeneration in Maple Syrup Urine Disease. Mol Neurobiol (2016) 0.76
Inverse relationship between Alzheimer's disease and cancer, and other factors contributing to Alzheimer's disease: a systematic review. BMC Neurol (2016) 0.75
ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy. Front Neurosci (2016) 0.75
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry (2010) 3.64
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial. Lancet (2012) 1.88
Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future. Alzheimers Dement (2013) 1.51
Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy. Drugs Aging (2004) 1.36
Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease. J Neurosci Res (2010) 1.13
Noradrenergic changes, aggressive behavior, and cognition in patients with dementia. Biol Psychiatry (2002) 1.12
Microvascular structure and network in the retina of patients with ischemic stroke. Stroke (2013) 1.08
Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease. J Neurochem (2006) 1.04
Astroglia-mediated effects of uric acid to protect spinal cord neurons from glutamate toxicity. Glia (2007) 1.03
Calsyntenin-1 mediates axonal transport of the amyloid precursor protein and regulates Aβ production. Hum Mol Genet (2012) 1.02
Increased Aβ production prompts the onset of glucose intolerance and insulin resistance. Am J Physiol Endocrinol Metab (2012) 1.02
Increased sensitivity to MPTP in human alpha-synuclein A30P transgenic mice. Neurobiol Aging (2005) 0.99
The prognostic effects of poststroke cognitive impairment no dementia and domain-specific cognitive impairments in nondisabled ischemic stroke patients. Stroke (2011) 0.98
Is uric acid protective or deleterious in acute ischemic stroke? A prospective cohort study. Atherosclerosis (2009) 0.98
Identification of novel α-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method. Neurochem Res (2011) 0.97
Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease. Brain Res (2003) 0.94
Neurochemical basis for symptomatic treatment of Alzheimer's disease. Neuropharmacology (2010) 0.93
Cholinergic imbalance in the multiple sclerosis hippocampus. Acta Neuropathol (2011) 0.91
Selective loss of P2Y2 nucleotide receptor immunoreactivity is associated with Alzheimer's disease neuropathology. J Neural Transm (Vienna) (2008) 0.91
Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells. J Neurochem (2008) 0.89
Long lasting effects of early-life stress on glutamatergic/GABAergic circuitry in the rat hippocampus. Neuropharmacology (2012) 0.89
Insulin levels are decreased in the cerebrospinal fluid of women with prodomal Alzheimer's disease. J Alzheimers Dis (2010) 0.88
Pro-oxidant diet enhances β/γ secretase-mediated APP processing in APP/PS1 transgenic mice. Neurobiol Aging (2010) 0.87
Abeta(1-42) modulation of Akt phosphorylation via alpha7 nAChR and NMDA receptors. Neurobiol Aging (2007) 0.87
CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients. Neurobiol Aging (2012) 0.86
HPA axis dysregulation associated to apolipoprotein E4 genotype in Alzheimer's disease. J Alzheimers Dis (2010) 0.86
Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease. Neurobiol Aging (2005) 0.86
Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti-agitation properties: focus on ligand-gated channels. J Pharm Pharmacol (2008) 0.86
Propranolol restores cognitive deficits and improves amyloid and Tau pathologies in a senescence-accelerated mouse model. Neuropharmacology (2012) 0.85
Inflammatory mediators in the frontal lobe of patients with mixed and vascular dementia. Dement Geriatr Cogn Disord (2008) 0.84
Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release. Eur J Neurosci (2006) 0.84
Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease. Neurobiol Dis (2006) 0.84
Cholinergic hypofunction impairs memory acquisition possibly through hippocampal Arc and BDNF downregulation. Hippocampus (2010) 0.84
Evaluation of cholinergic markers in Alzheimer's disease and in a model of cholinergic deficit. Neurosci Lett (2004) 0.84
Pharmacokinetic and pharmacodynamic properties of cholinesterase inhibitors donepezil, tacrine, and galantamine in aged and young Lister hooded rats. Drug Metab Dispos (2010) 0.83
Clusterin associates specifically with Aβ40 in Alzheimer's disease brain tissue. Brain Pathol (2013) 0.83
Upregulation of AMPA receptor GluR2 (GluA2) subunits in subcortical ischemic vascular dementia is repressed in the presence of Alzheimer's disease. Neurochem Int (2011) 0.83
Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease. Neuroreport (2002) 0.83
Association of a polymorphism in mitochondrial transcription factor A (TFAM) with Parkinson's disease dementia but not dementia with Lewy bodies. Neurosci Lett (2013) 0.82
Hippocampal neurofibrillary tangle changes and aggressive behaviour in dementia. Neuroreport (2010) 0.82
Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex. Neurochem Int (2010) 0.82
Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease. Neurobiol Aging (2005) 0.81
Effects of early maternal separation on biobehavioral and neuropathological markers of Alzheimer's disease in adult male rats. Curr Alzheimer Res (2013) 0.81
Increased binding to 5-HT1A and 5-HT2A receptors is associated with large vessel infarction and relative preservation of cognition. Brain (2009) 0.81
Cdk5-mediated phosphorylation of delta-catenin regulates its localization and GluR2-mediated synaptic activity. J Neurosci (2010) 0.80
Memantine potentiates hippocampal θ oscillations at a therapeutic dose in anesthetized mice: a mechanistic link to its cognitive-enhancing properties. Neuropharmacology (2012) 0.80
Genetic associations of autopsy-confirmed vascular dementia subtypes. Dement Geriatr Cogn Disord (2011) 0.80
Signalling pathways associated with 5-HT6 receptors: relevance for cognitive effects. Int J Neuropsychopharmacol (2009) 0.80
Arterial stiffness is associated with intracranial large artery disease among ethnic Chinese and South Asian ischemic stroke patients. J Hypertens (2009) 0.80
Involvement of an altered 5-HT -{6} receptor function in behavioral symptoms of Alzheimer's disease. J Alzheimers Dis (2008) 0.80
Aggressive behavior and neuroleptic medication are associated with increased number of alpha1-adrenoceptors in patients with Alzheimer disease. Am J Geriatr Psychiatry (2007) 0.80
GABA(A) receptor antagonists enhance cortical acetylcholine release induced by 5-HT(3) receptor blockade in freely moving rats. Brain Res (2002) 0.80
Differential involvement of hippocampal serotonin1A receptors and re-uptake sites in non-cognitive behaviors of Alzheimer's disease. Psychopharmacology (Berl) (2010) 0.79
Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status. Drugs (2014) 0.79
Early cognitive stimulation compensates for memory and pathological changes in Tg2576 mice. Biochim Biophys Acta (2013) 0.79
A serotoninergic basis for hyperphagic eating changes in Alzheimer's disease. J Neurol Sci (2009) 0.79
Choline acetyltransferase activity in vascular dementia and stroke. Dement Geriatr Cogn Disord (2009) 0.79
Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson's disease dementia. Dement Geriatr Cogn Disord (2008) 0.79
Amyloid beta concentrations in older people with Down syndrome and dementia. Neurosci Lett (2008) 0.79
Pharmacological profile of an essential oil derived from Melissa officinalis with anti-agitation properties: focus on ligand-gated channels. J Pharm Pharmacol (2008) 0.79
Cholinergic and glutamatergic drugs in Alzheimer's disease therapy. Expert Rev Neurother (2005) 0.78
Proteasome inhibition leads to early loss of synaptic proteins in neuronal culture. J Neural Transm (Vienna) (2012) 0.78
Treatment Options in Alzheimer´s Disease: The GABA Story. Curr Pharm Des (2015) 0.78
iTRAQ quantitative clinical proteomics revealed role of Na(+)K(+)-ATPase and its correlation with deamidation in vascular dementia. J Proteome Res (2014) 0.78
Preservation of cortical histamine H3 receptors in ischemic vascular and mixed dementias. J Neurol Sci (2011) 0.78
Tau phosphorylation in human brain: relationship to behavioral disturbance in dementia. Neurobiol Aging (2012) 0.77
Synthesis, physical-chemical characterisation and biological evaluation of novel 2-amido-3-hydroxypyridin-4(1H)-ones: Iron chelators with the potential for treating Alzheimer's disease. Bioorg Med Chem (2010) 0.77
Non-polio AFP rate and polio eradication. Indian Pediatr (2008) 0.77
Maternal vaccination against pertussis. Lancet Infect Dis (2008) 0.77
Changes in hippocampal SNAP-25 expression following afferent lesions. Brain Res (2004) 0.77
Antipsychotic medication is associated with selective alterations in ventricular cerebrospinal fluid Aβ 40 and tau in patients with intractable unipolar depression. Int J Geriatr Psychiatry (2011) 0.77
Decreased immunoreactivities of neocortical AMPA receptor subunits correlate with motor disability in Lewy body dementias. J Neural Transm (Vienna) (2013) 0.76
Serotonin transporters are preserved in the neocortex of anxious Alzheimer's disease patients. Neuroreport (2003) 0.76
Facilitation of cholinergic transmission by combined treatment of ondansetron with flumazenil after cortical cholinergic deafferentation. Neuropharmacology (2004) 0.76
Growth differentiation factor-15 and white matter hyperintensities in cognitive impairment and dementia. Medicine (Baltimore) (2016) 0.76
Mechanisms involved in BACE upregulation associated to stress. Curr Alzheimer Res (2012) 0.76
Analysis of chiral amino acids in cerebrospinal fluid samples linked to different stages of Alzheimer disease. Electrophoresis (2011) 0.76
Protective efficacy of a monovalent oral type 1 poliovirus vaccine. Lancet (2007) 0.75
Neurochemical changes in a double transgenic mouse model of Alzheimer's disease fed a pro-oxidant diet. Neurochem Int (2010) 0.75
Synaptic protein expression is regulated by a pro-oxidant diet in APPxPS1 mice. J Neural Transm (Vienna) (2011) 0.75
Corrigendum: Macrophage Migration Inhibitory Factor is subjected to glucose modification and oxidation in Alzheimer's Disease. Sci Rep (2017) 0.75
Let Sabin guide polio eradication in India. Indian Pediatr (2008) 0.75
Effects of chronic blockade of 5-HT(6) receptors on NMDA receptor subunits expression. Synapse (2009) 0.75
Myeloid-Cell-Derived VEGF Maintains Brain Glucose Uptake and Limits Cognitive Impairment in Obesity. Cell (2016) 0.75